FMR1 and fragile X-associated tremor/ataxia syndrome: We also verified whether RPS26 silencing would affect FMRP endogenously expressed in FXTAS patient-derived and control fibroblasts, as they differ in CGG repeats content in natural locus of FMR1, which potentially might influence the effect of RPS26 deficiency.